IMGT-ONTOLOGY, IMGT® Databases, Tools, and Web Resources for Immunoinformatics
Immunoinformatics and Reverse Vaccinology, Potential Application to Development of an ASF Vaccine
-
Upload
ilri -
Category
Technology
-
view
2.242 -
download
1
description
Transcript of Immunoinformatics and Reverse Vaccinology, Potential Application to Development of an ASF Vaccine
Immunoinformatics and Reverse Vaccinology, Potential Application to
Development of an ASF Vaccine
Nicholas SvitekPostdoctoral Scientist
ILRI-Kenya
Presentation Outline
• My postdoctoral project: “Develop an immunoinformatic approach for the identification of immunodominant peptides from Theileria parva”
• Tools: ANN, Peptide-MHC tetramer• How immunoinformatics can be used for ASF
vaccine research
Phylogenetic Classification of T. parva
Adapted from PNAS
Alveolata
∼613mya
∼480mya
∼420mya
∼350mya
ApicomplexaPlasmodium
Babesia
Theileria
CoccidiaCiliophora
Dinoflagellata
Chromera velia
Gregarina
Cryotosporidium
Eimeria Sarcocystis
Toxoplasma
Neospora
Apicomplexans of medical and veterinary importance
ParasitePlasmodiumTheileria
HostsPrimates, birds, rodents, reptilesCattle, sheep, horses, buffalos
Theileria parva Pathogenesis• Transformation of leucocytes
– T lymphocytes• Macrophages can be infected but are not
transformed– NF-kB– Anti-apopotic c-Myc/Mcl-1– Increased Tgf-b2
• Invasion of lymphoid and non-lymphoid tissues with proliferating infected lymphoblasts– Susceptible animals die within 3-4
weeks of infection• 1 million die each year• Annual losses of more than 300
million USD($)
The Need for a Better Vaccine
• “Infection and treatment” immunization method (ITM): induction of long-term immunity based on CD8+ (cytotoxic) T cell responses.
• Variable protection against heterologous strains.
• Economic and logistic disadvantages:•Difficult to produce•Delivery requires a cold chain
High priority to produce a recombinant vaccine
Nature Reviews Immunology
Goal
Use a reverse immunology approach for the identification of immunodominant peptides
from Theileria parva
Develop a better recombinant vaccine
Reverse ImmunologyWhole Genome Sequence
from T. parvaIn silico antigen predictions In vitro characterization of
predicted antigens
Selection of immunodominant peptides
VGYPKVKEEMLSHEELKKLGML
TGASIQTTLSKADVIAKY
Prime/BoostNaïve cattles
Challenge with T. parva
Computer algorithmsTrained on biological data
- Poxvirus175,000 peptides
- Proteolytic liberation35,000 peptides
- TAP transport30,000 peptides
- Class I binding150 peptides
- TCR recognition75 peptides
“Immunodomination”50 peptides
- Theileria parva4079 proteins
?
?
?
?
?
-Transmembrane/Secreted proteins200/738 (pred.) proteins
- Proteasomal degradation?? proteins
- TAP transport?? peptides
?
- Class I binding?? peptides
- TCR recognition?? peptides
“Immunodomination”?? peptides
Immunodominance
The MHC Class I Molecule
LeaderPeptide α1 domain α2 domain α3 domain Trans-
membraneCyto-
plasmic
Exon1Exon2
Exon3Exon4
Exon5Ex6
78
1 kb
360 aa
Ex1 Ex2 Ex3 Ex4 Ex5 Ex6 Ex7 Ex85 kb
Sequencing Bovine MHC class I Genes
16 cattle
RNA isolation from PBMCs
454 pyrosequencing
RT-PCR
Full length cDNAExon 2- Exon 3
Exon2
Exon3
α1 α2
•High throughput •Rare variants
NetMHCpan• Predicts binding of peptides to any known MHC
molecule using artificial neural networks (ANN).• Trained on more than 115,000 quantitative
binding data covering more than 120 different MHC molecules.
• MHC class I: humans, non-human primates (chimpanzee, rhesus macaque, gorilla), mice, pigs, and cattle.
• Includes the newest MHC allele releases from the IMGT/HLA & IPD-MHC databases.
Artificial Neural Network (ANN)Biological Neural Network Artificial Neural Network
Input neuronsPeptide/MHC seq
Hidden neurons
Output neuronsBinding affinity
Mathematical function whichdetermines the activation of
the neuron (weight)Computing units
Comparison Between Predicted and Actual Peptide Binding
NetMHCpan 2.0 (older version)
Hoof I, et al. Immunogenetics. 2009
Macaque Chimpanzee
Pig
Recombinant MHC Production
Complex formation
E. coli expression
Peptide-binding assaysRecombinant MHC class IHeavy chain
β2m
Peptide-MHC Tetramer StainingMHC-peptide
biotin
streptavidin
Fluorochrome: PEAntigen-specific
CD8+ T Cell
TCR
biotin
CD8+
CD8+/Tetramer +
• Allow for accurate and rapid enumeration of antigen-specific T cells• Specific• Sensitive
Immune Responses Towards AFSThe CTL Response
Nature Reviews Immunology
• Martins, CLV., et al. 1993• Ramiro-Ibanez, F., 1997• Jenson, JS., et al. 2000• Oura, CAL., et al. 2005
Reverse Immunology for ASFV ResearchWhole ASFV Genome Sequence In silico antigen predictions In vitro characterization of
predicted antigens
Selection of immunodominant peptides
VGYPKVKEEMLSHEELKKLGML
TGASIQTTLSKADVIAKY
Prime/BoostNaïve pigs
Challenge with virulent ASFV
Computer algorithmstrained on biological data
- Poxvirus175,000 peptides
- Proteolytic liberation35,000 peptides
- TAP transport30,000 peptides
- Class I binding150 peptides
- TCR recognition75 peptides
“Immunodomination”50 peptides
- African Swine Fever Virus150 proteins
- Class I binding?? peptides
- TCR recognition?? peptides
“Immunodomination”?? peptides
Immunodominance
- Proteolytic liberation?? peptides
- TAP transport?? peptides
Research Design1. Sequencing SLA class 1 cDNA
– Expression profile– Number of variants
2. Predict ASFV peptide binding in MHC I (in silico)NetMHCpan 2.4 server
3. Identify in vitro the “true” immunodominant ASFVpeptides – MHC-peptide tetramer staining– ELIspot assay– CTL cell lysis assay (chromium release)
Summary and Perspectives
• Tools (NetMHCpan, tetramers) are available and functional to identify CTL epitopes in ASFV.
• Understanding more precisely the immune response elicited towards ASFV.
• Develop vaccines • Vaccinogenomics.
– Integrating pathogen and host genomics in vaccine research (delivreing specific peptide mix to pigs with particular MHC class I expression).
Basic Research to Enable Agricultural Development (BREAD)
Acknowledgments
Vish Nene (PI)Phil ToyeÉtienne de VilliersAnne FischerGeorge MichukiRoger PelléLucilla SteinaaNelson NdegwaFrederick MogebiRichard Bishop
John Barlow (PI)
William T. Golde (PI)
Søren Buus (Tetramers)
Morten Nielsen (NetMHCpan)
Known T. parva Antigens Among Top 6%T. parva Ag Bovine MHC I Peptide Length Immunodominance Percentage (%)
Tp1 N*01301 VGYPKVKEEML 11-mer 30th / 514 5.84
Tp2 N*04001 SHEELKKLGML 11-mer 11th /1 41 7.80
Tp2 N*01201 KSSHGMGKVGK 11-mer 4th / 141 2.84
Tp2 N*01201 QSLVCVLMK 9-mer 3rd / 141 2.13
Tp2 T2c FAQSLVCVL 9-mer 3rd / 141 2.13
Tp4 N*00101 TGASIQTTL 9-mer 42nd / 571 7.36
Tp5 N*00902 SKADVIAKY 9-mer 1st / 141 0.71
Tp7 N*04701 EFISFPISL 9-mer 73rd /7 13 10.24
Tp8 N*00101 CGAELNHFL 9-mer 44th / 432 10.19
Tp9 N*02301 AKFPGMKKSK 10-mer 38th / 325 11.69
Peptide Binding in the MHC Class I Molecule
GSHSLRYFYTAVSRPGLGEPRFISVGYVDDTQFVRFDSDAPNPREEPRAPWIEKEGPEYWDRETRISKENTLVYRESLNNLRGYYNQSEAGSHTLQLMYGCDVGPDGRLLRGYRQDAYDSRDYIALNEELRSWTAADTAAQITKRKWEAEGYAESLRNYLEGRCVEWLRRYLENGKDALLRADPPMAHVTHHPSSEREVTLRCWALGFYPKEISLTWQREGEDQTQDMELVETRPSGDGTFQKWAALVVPSGEEQKYTCHVQHEGLQEPLILRWEPPQTSFLIMGIIVGLVLLVVAVVAGAVIWRKKRSGEKRQTHTQAASGDSDQGSDVSRMVPKA*